Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 2
1998 2
2000 1
2003 5
2005 2
2006 3
2008 5
2009 4
2010 3
2011 8
2012 11
2013 6
2014 9
2015 10
2016 4
2017 12
2018 3
2019 6
2020 12
2021 11
2022 10
2023 11
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Strengthening the Family - the 'Five-I' Approach.
Kalra S, Saboo B, Cho NH, Sadikot S, Hasnani D, Chandarana H, Verma M, Bhandari S, Gupta A, Aravind SR. Kalra S, et al. Among authors: aravind sr. Eur Endocrinol. 2019 Apr;15(1):15-16. doi: 10.17925/EE.2019.15.1.15. Epub 2019 Apr 12. Eur Endocrinol. 2019. PMID: 31244905 Free PMC article.
Chitosan-based scaffolds as drug delivery systems in bone tissue engineering.
Bharathi R, Ganesh SS, Harini G, Vatsala K, Anushikaa R, Aravind S, Abinaya S, Selvamurugan N. Bharathi R, et al. Among authors: aravind s. Int J Biol Macromol. 2022 Dec 1;222(Pt A):132-153. doi: 10.1016/j.ijbiomac.2022.09.058. Epub 2022 Sep 13. Int J Biol Macromol. 2022. PMID: 36108752 Review.
Role and importance of high fiber in diabetes management in India.
Saboo B, Misra A, Kalra S, Mohan V, Aravind SR, Joshi S, Chowdhury S, Sahay R, Kesavadev J, John M, Kapoor N, Das S, Krishnan D, Salis S; Diabetes India ‘Decode Fiber’ Expert Consensus Group. Saboo B, et al. Among authors: aravind sr. Diabetes Metab Syndr. 2022 May;16(5):102480. doi: 10.1016/j.dsx.2022.102480. Epub 2022 Apr 22. Diabetes Metab Syndr. 2022. PMID: 35594690 Free article. Review.
Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM. Ghosh S, et al. Among authors: aravind sr. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S507-S521. doi: 10.1016/j.dsx.2017.03.045. Epub 2017 Apr 5. Diabetes Metab Syndr. 2017. PMID: 28433618 Review.
Alginate-based drug carrier systems to target inflammatory bowel disease: A review.
Swastha D, Varsha N, Aravind S, Samyuktha KB, Yokesh MM, Balde A, Ayilya BL, Benjakul S, Kim SK, Nazeer RA. Swastha D, et al. Among authors: aravind s. Int J Biol Macromol. 2023 Jul 31;244:125472. doi: 10.1016/j.ijbiomac.2023.125472. Epub 2023 Jun 17. Int J Biol Macromol. 2023. PMID: 37336375 Review.
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig.
Mondal P, Patel NS, Bailey K, Aravind S, Cartwright SB, Hollingsworth MA, Lazenby AJ, Carlson MA. Mondal P, et al. Among authors: aravind s. Dis Model Mech. 2023 Jan 1;16(1):dmm049699. doi: 10.1242/dmm.049699. Epub 2023 Jan 16. Dis Model Mech. 2023. PMID: 36579622 Free PMC article.
Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach.
Das AK, Saboo B, Chawla R, Aravind SR, Rajput R, Singh AK, Mukherjee JJ, Jhingan A, Shah P, Deshmukh V, Kale S, Jaggi S, Sridhar GR, Dhediya R, Gaurav K. Das AK, et al. Among authors: aravind sr. Int J Diabetes Dev Ctries. 2023 Apr 19:1-19. doi: 10.1007/s13410-023-01192-6. Online ahead of print. Int J Diabetes Dev Ctries. 2023. PMID: 37360324 Free PMC article. Review.
141 results